DNA Methylation and Type 2 Diabetes: Novel Biomarkers for Risk Assessment?
Diabetes is a severe threat to global health. Almost 500 million people live with diabetes worldwide. Most of them have type 2 diabetes (T2D). T2D patients are at risk of developing severe and life-threatening complications, leading to an increased need for medical care and reduced quality of life....
Main Authors: | Gregory Alexander Raciti, Antonella Desiderio, Michele Longo, Alessia Leone, Federica Zatterale, Immacolata Prevenzano, Claudia Miele, Raffaele Napoli, Francesco Beguinot |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-10-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/22/21/11652 |
Similar Items
-
Epigenetic Reprogramming of the Inflammatory Response in Obesity and Type 2 Diabetes
by: Federica Zatterale, et al.
Published: (2022-07-01) -
Methylglyoxal Impairs the Pro-Angiogenic Ability of Mouse Adipose-Derived Stem Cells (mADSCs) via a Senescence-Associated Mechanism
by: Alessia Leone, et al.
Published: (2023-06-01) -
Altered H3K4me3 profile at the TFAM promoter causes mitochondrial alterations in preadipocytes from first-degree relatives of type 2 diabetics
by: Michele Longo, et al.
Published: (2023-09-01) -
Epigenetic Dysregulation of the <i>Homeobox A5</i> (<i>HOXA5</i>) Gene Associates with Subcutaneous Adipocyte Hypertrophy in Human Obesity
by: Luca Parrillo, et al.
Published: (2022-02-01) -
The Destiny of Glucose from a MicroRNA Perspective
by: Paola Mirra, et al.
Published: (2018-02-01)